December 4, 2024
GSK Expands Eastern Partnerships with $30M Option on DualityBio’s Preclinical ADC
GSK, DualityBio, ADC, Preclinical, Biotech, Pharmaceutical Partnerships
Lil Jon Teams Up with Singing Toilet for Unconventional Cancer Awareness Campaign
Lil Jon, scat rap, singing toilet, Exact Sciences, cancer kit, promotional campaign
Coherus BioSciences Completes Strategic Shift with $483M Sale of Last Biosimilar Asset
Coherus BioSciences, biosimilars, strategic pivot, pharmaceutical industry, biotechnology
UnitedHealthcare CEO Brian Thompson Fatally Shot in Targeted Attack Outside New York City Hotel
UnitedHealthcare, CEO Brian Thompson, targeted killing, New York City, hotel shooting, investor meeting
Biocon Biologics Secures FDA Approval for YESINTEK, a Biosimilar to Stelara
Biocon Biologics, FDA approval, YESINTEK, Stelara biosimilar, ustekinumab, inflammatory diseases
FDA Rejects Applied Therapeutics’ Rare Disease Drug Govorestat, Citing Clinical Application Deficiencies
Applied Therapeutics, FDA rejection, govorestat, galactosemia, rare metabolic disease, clinical application deficiencies
Relay Therapeutics Partners with Elevar Therapeutics in $500M Deal for Lirafugratinib in Rare Cancer Treatment
Relay Therapeutics, Elevar Therapeutics, Lirafugratinib, FGFR2-Driven Cholangiocarcinoma, Rare Cancer Treatment, Biotech Partnership
Maze Therapeutics Secures $115 Million Series D Funding to Advance Clinical-Stage Kidney Disease Programs
Maze Therapeutics, Series D funding, kidney disease, clinical-stage programs, precision medicine, APOL1 kidney disease, chronic kidney disease, MZE829, MZE782.
GSK Terminates Hepatitis B Vaccine Trial Due to Efficacy Shortfalls
GSK, Hepatitis B Vaccine, Clinical Trial Termination, Efficacy Issues
Alligator Bioscience Slashes 70% of Workforce Due to Financial Strains
Alligator Bioscience, staff cuts, capital constraints, biopharma industry, financial challenges